GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...

GSK plc GSK announced positive topline results from a phase III study evaluating the co-administration of its two marketed ...

(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and ...

Drug maker GSK plc (GSK, GSK.L) confirmed Wednesday that it has reached two confidential settlements in cases filed in California ...

Already competing to bring the first vaccine against respiratory syncytial virus (RSV) to market, Pfizer and GSK are also fighting ... the next few weeks. In the US alone, RSV infections account ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

With our co-administration studies, GSK is using its science and technology to help remove barriers to adult immunization, by potentially reducing the number of visits to the healthcare offices and ...

GSK plc (LSE/NYSE: GSK) is partnering with Brooke Shields, as part of its THRIVE@50+ campaign, to encourage people 50 and ...

Britain’s high streets received a boost last month after warmer weather and end-of-season sales drew in more customers.

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

In July, sources close to Harry told PEOPLE that his ongoing legal battle over the lack of official security for him and his ...

COPD is the third leading cause of death worldwide with exacerbations accounting for the greatest proportion of the total ...